Small Molecules

09 Oct 2007 Karo Bio has presented positive KB2115 Phase II data at two international scientific congresses
09 Oct 2007 Ocera Therapeutics, Inc. Completes Enrollment in FHAST1, a Pivotal Phase 3 Clinical Trial in Fistulizing Crohn's Disease
09 Oct 2007 EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407
09 Oct 2007 GlaxoSmithKline and Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics based on boron chemistry
09 Oct 2007 Akesis Pharmaceuticals Files IND for Phase IIa Trial of AKP-020 to Treat Type 2 Diabetes
09 Oct 2007 Phase III Clinical Product Development Update
09 Oct 2007 Phase III clinical product development update
06 Oct 2007 Bionomics Anti-Cancer Compound Targets Tumor, not Healthy Tissue
06 Oct 2007 OXiGENE Reports Positive Interim Results from Phase Ib ZYBRESTAT(TM) - Bevacizumab Combination Study in Advanced Solid Tumors
06 Oct 2007 Aclasta(R) receives European approval as first once-yearly treatment for postmenopausal osteoporosis
06 Oct 2007 Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
06 Oct 2007 Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
06 Oct 2007 Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens
05 Oct 2007 Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
05 Oct 2007 TopoTarget and Lundbeck sign agreement forsiramesine, a new and promising mechanism in cancer therapy
05 Oct 2007 Speedel's Third Renin Inhibitor Advances to the Clinic
05 Oct 2007 Hollis-Eden Pharmaceuticals Presents Positive Results with Novel Drug Candidate HE3235 in Model of Hormone Independent Prostate Cancer
05 Oct 2007 Nestle Nutrition and Phosphagenics to commence Phospha E(R) phase 2 clinical trial
05 Oct 2007 Inspire Completes Enrollment in Phase 3 Cystic Fibrosis Trial
05 Oct 2007 Merck's Investigational CETP-Inhibitor, MK-0859 (anacetrapib), Produced Positive Effects on Lipids with No Observed Blood Pressure Changes in Phase IIb Study
05 Oct 2007 Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
04 Oct 2007 Critical Therapeutics Initiates Phase II Clinical Trial for Zileuton Injection
04 Oct 2007 Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
04 Oct 2007 Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
04 Oct 2007 Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up